Earnings Call Insights: Nu Skin Enterprises (NYSE:NUS) Q4 2024 Adjusted earnings per share exceeded projections, and revenue of $445.6M came in above guidance despite a $20.1M foreign currency impact.

Nu Skin Enterprises Inc specializes in beauty and wellness products, offering a wide range of items including skin care devices, cosmetics, and personal care products like the ageLOC LumiSpa series.

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses ...

The company said, “We are encouraged by our recent progress in strengthening our business by driving sequential growth in our core Nu Skin (NUS) business, improving operational efficiencies and ...

Personal care company Nu Skin (NYSE:NUS) reported Q4 CY2024 results topping the market’s revenue expectations , but sales fell by 8.8% year on year to $445.6 million. On the other hand, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Napierski outlined three strategic priorities for 2025: strengthening the Nu Skin core business, accelerating innovation in the iO intelligent beauty and wellness platform, and improving ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...